• Contact Us
  • FI
  • SE
FICAN West
  • Home
  • FicanWest
    • Personnel
    • Organization and strategy
    • Collaboration
    • Research and development projects
  • For patients
    • Care pathways
    • Access to treatment
    • Join a cancer trial
    • Support to patients
    • Wellness
    • Rehabilitation
    • Family and friends
    • The Cancer Centre’s Client Board
  • For professionals
    • GeneCa
    • Molecular Tumor Board
    • Care Instructions
    • Education
  • For researchers
    • Ongoing Clinical Trials
    • Research groups
    • For medical industry
  • News
  • Search
  • Menu
  • Home
  • FicanWest
    • Personnel
    • Organization and strategy
    • Collaboration
    • Research and development projects
  • For patients
    • Care pathways
    • Access to treatment
    • Join a cancer trial
    • Support to patients
    • Wellness
    • Rehabilitation
    • Family and friends
    • The Cancer Centre’s Client Board
  • For professionals
    • GeneCa
    • Molecular Tumor Board
    • Care Instructions
    • Education
  • For researchers
    • Ongoing Clinical Trials
    • Research groups
    • For medical industry
  • News

    Molecular Tumor Board (MTB)

    Increased knowledge of cancer molecular biology and research methods development has enabled the spread of gene-guided treatment of cancer. Molecular Tumor Board’s (MTB) mission is to implement and develop personalized cancer care in the VSSHP area.

    The MTB is a monthly multidisciplinary meeting attended by cancer physicians, pathologists, geneticists, clinical chemists, and molecular biology experts. The meeting will address cancer patient cases in which a comprehensive genomic profiling test has been performed on a cancer sample or blood. Based on the molecular changes found in gene profiling, the aim is to obtain more information about the nature of the cancer, to find the optimal drug treatment for the cancer, and to provide an assessment of the possible heritability of the genetic change and the need for further studies. In addition, the meeting will address a wide range of current issues related to gene-guided cancer treatment to increase physicians awareness.

    Hospital Districts

    The Hospital District of Southwest Finland

    The Hospital District of Satakunta Region (in Finnish)

    Vaasa Hospital District

    • FICAN West
    • For patients
    • For professionals
    • For researchers
    • Contact
    • European Reference Networksin logoEuropean Reference Networks
    • Satakunnan sairaanhoitopiirin logoSatasairaala – satakunnan sairaanhoitopiiri
    • Varsinais-Suomen sairaanhoitopiirin logoVarsinais-Suomen sairaanhoitopiiri
    • Vaasan sairaanhoitopiirin logoVaasan sairaanhoitopiiri
    • Turun yliopiston logoTurun yliopisto
    • Turun yliopistollisen keskussairaalan logoTYKS – Turun yliopistollinen keskussairaala
    • Organisation European Cancer InstituteOECI – Organisation European Cancer Institute
    Scroll to top